Caroline Z Berton, Caroline Brogliato, Ivan H Yoshida, Laura T Vellez, Claudia H Suganuma, Emerson B Cordts, Gabriel S Conceição, Caio P Barbosa
{"title":"癌症生育能力保存:来自巴西社会项目的报告。","authors":"Caroline Z Berton, Caroline Brogliato, Ivan H Yoshida, Laura T Vellez, Claudia H Suganuma, Emerson B Cordts, Gabriel S Conceição, Caio P Barbosa","doi":"10.5935/1518-0557.20190089","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To present clinical and laboratory data of a Brazilian social program for cancer fertility preservation.</p><p><strong>Methods: </strong>We carried out a descriptive observational study between July 2011 and December 2018. 246 patients were included from a social program in a private assisted reproduction clinic in Santo André/Brazil for oocyte cryopreservation before starting oncological treatment.</p><p><strong>Results: </strong>246 cancer patients resorted to fertility preservation before initiating cancer treatment. These were diagnosed with 27 different types of cancer, and the breast type is the most prevalent. 2528 MII oocytes (mean of 10.3 oocytes per patient) were vitrified. Four patients thawed their oocytes to submit in vitro fertilization, three had embryos transferred and one achieved pregnancy.</p><p><strong>Conclusion: </strong>Preservation of fertility offers patients, especially at reproductive age, a viable way to perform their cancer treatment without compromising future gestation. It is important that professionals duly counsel oncological patients so, if they wish, they can have the possibility to guarantee her fertility preserved.</p>","PeriodicalId":520656,"journal":{"name":"JBRA assisted reproduction","volume":" ","pages":"302-304"},"PeriodicalIF":1.9000,"publicationDate":"2020-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365537/pdf/","citationCount":"3","resultStr":"{\"title\":\"Cancer fertility preservation: a report from a Brazilian social program.\",\"authors\":\"Caroline Z Berton, Caroline Brogliato, Ivan H Yoshida, Laura T Vellez, Claudia H Suganuma, Emerson B Cordts, Gabriel S Conceição, Caio P Barbosa\",\"doi\":\"10.5935/1518-0557.20190089\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To present clinical and laboratory data of a Brazilian social program for cancer fertility preservation.</p><p><strong>Methods: </strong>We carried out a descriptive observational study between July 2011 and December 2018. 246 patients were included from a social program in a private assisted reproduction clinic in Santo André/Brazil for oocyte cryopreservation before starting oncological treatment.</p><p><strong>Results: </strong>246 cancer patients resorted to fertility preservation before initiating cancer treatment. These were diagnosed with 27 different types of cancer, and the breast type is the most prevalent. 2528 MII oocytes (mean of 10.3 oocytes per patient) were vitrified. Four patients thawed their oocytes to submit in vitro fertilization, three had embryos transferred and one achieved pregnancy.</p><p><strong>Conclusion: </strong>Preservation of fertility offers patients, especially at reproductive age, a viable way to perform their cancer treatment without compromising future gestation. It is important that professionals duly counsel oncological patients so, if they wish, they can have the possibility to guarantee her fertility preserved.</p>\",\"PeriodicalId\":520656,\"journal\":{\"name\":\"JBRA assisted reproduction\",\"volume\":\" \",\"pages\":\"302-304\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2020-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365537/pdf/\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JBRA assisted reproduction\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5935/1518-0557.20190089\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBRA assisted reproduction","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5935/1518-0557.20190089","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cancer fertility preservation: a report from a Brazilian social program.
Objective: To present clinical and laboratory data of a Brazilian social program for cancer fertility preservation.
Methods: We carried out a descriptive observational study between July 2011 and December 2018. 246 patients were included from a social program in a private assisted reproduction clinic in Santo André/Brazil for oocyte cryopreservation before starting oncological treatment.
Results: 246 cancer patients resorted to fertility preservation before initiating cancer treatment. These were diagnosed with 27 different types of cancer, and the breast type is the most prevalent. 2528 MII oocytes (mean of 10.3 oocytes per patient) were vitrified. Four patients thawed their oocytes to submit in vitro fertilization, three had embryos transferred and one achieved pregnancy.
Conclusion: Preservation of fertility offers patients, especially at reproductive age, a viable way to perform their cancer treatment without compromising future gestation. It is important that professionals duly counsel oncological patients so, if they wish, they can have the possibility to guarantee her fertility preserved.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
